TherapeuticsMD (TXMD) – Analyst Ratings
-
Cantor Fitzgerald Reinstates TherapeuticsMD (TXMD) at Neutral
-
Cantor Fitzgerald Reiterates Neutral Rating, $1 Price Target on TherapeuticsMD (TXMD) on Failed Acquisition
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TXMD Stock Lookup